These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Couzin J Science; 2004 Oct; 306(5695):384-5. PubMed ID: 15486258 [No Abstract] [Full Text] [Related]
30. Drug pullout. Massive recall of Vioxx poses logistical problems. Becker C Mod Healthc; 2004 Oct; 34(42):17. PubMed ID: 15552189 [No Abstract] [Full Text] [Related]
31. [Cyclooxygenase-2 inhibitors and the ethics of research]. Gherardi CR Medicina (B Aires); 2005; 65(5):476. PubMed ID: 16296649 [No Abstract] [Full Text] [Related]
32. How to avoid another 'Vioxx'. Frantz S Nat Rev Drug Discov; 2005 Jan; 4(1):5-7. PubMed ID: 15690595 [No Abstract] [Full Text] [Related]
33. Rofecoxib, Merck, and the FDA. Kim PS; Reicin AS N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625342 [No Abstract] [Full Text] [Related]
34. Vioxx's history and the need for better procedures and better testing. Gilhooley M Seton Hall Law Rev; 2007; 37(4):941-68. PubMed ID: 18363218 [No Abstract] [Full Text] [Related]
35. Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf. Nesi T US News World Rep; 2008 Nov 3-10; 145(10):64. PubMed ID: 18998444 [No Abstract] [Full Text] [Related]
36. COX-2 inhibitors--a lesson in unexpected problems. Drazen JM N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947 [No Abstract] [Full Text] [Related]
37. COX-2 inhibitors--lessons in drug safety. Psaty BM; Furberg CD N Engl J Med; 2005 Mar; 352(11):1133-5. PubMed ID: 15713946 [No Abstract] [Full Text] [Related]
38. Evaluating drug effects in the post-Vioxx world: there must be a better way. Avorn J Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873 [No Abstract] [Full Text] [Related]
39. Drug safety special: the safety catch. Wadman M Nature; 2005 Mar; 434(7033):554-6. PubMed ID: 15800591 [No Abstract] [Full Text] [Related]
40. Rofecoxib, Merck, and the FDA. Wolfe MM N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625749 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]